| 000 | 01508 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514002231.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 eng d | ||
| 022 | _a1567-5769 | ||
| 024 | 7 |
_a10.1016/s1567-5769(01)00039-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOssege, L M | |
| 245 | 0 | 0 |
_aImmunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cJun 2001 |
||
| 300 |
_a1085-100 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Situ Hybridization |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 |
_aLymphocyte Subsets _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aTissue Fixation |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
| 700 | 1 | _aSindern, E | |
| 700 | 1 | _aPatzold, T | |
| 700 | 1 | _aMalin, J P | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 1 _gno. 6 _gp. 1085-100 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1567-5769(01)00039-x _zAvailable from publisher's website |
| 999 |
_c11337564 _d11337564 |
||